Aurigene to Present Multiple Programs at the SITC 2018 in Washington D.C. and EORTC-NCI-AACR 2018 in Dublin
Aurigene:
SITC - Nov 7-11, Washington D.C.:
(a) CA-170 - Small molecule oral antagonist of PD-L1/VISTA in Ph-2 (India)
(b) Small molecule oral antagonist of CD47
(c) Small molecule oral antagonist of TIGIT/PD-L1
EORTC-NCI-AACR - Nov 13-16, Dublin:
a. Covalent, highly selective CDK12 inhibitors
b. Degrader of SMARCA2/4
c. Dual antagonists of TIGIT and PD-1 pathways
d. Dual inhibitors of CD73 and A2AR
Details: SITC, Nov 7-11 Washington D.C.
CA-170 Small Molecule Oral Antagon...